特定蛋白质市场:开发平台报告(开发阶段，市场区隔，地区·国家，法规途径，主要企业等)，2022年最新版

本报告提供特定蛋白质市场相关调查，产品概要与正在开发的开发中产品趋势，参与企业的最近趋势等资讯。

目录

第1章 目录

第2章 简介

第3章 开发中的产品

• 特定蛋白质- 各开发阶段平台产品
• 特定蛋白质- 各市场区隔开发中产品
• 特定蛋白质- 各地区开发中产品
• 特定蛋白质- 各法规途径开发中产品
• 特定蛋白质- 各估计核准日开发中产品
• 特定蛋白质- 进行中的临床试验

第4章 特定蛋白质- 企业正在开发的开发中产品

• 特定蛋白质企业- 各开发阶段平台产品
• 特定蛋白质- 各开发阶段平台产品

第5章 特定蛋白质的企业与产品概要

• Alfa Wassermann Diagnostic Technologies, LLC
• Amerimmune LLC
• Beckman Coulter Inc
• China Medical Technologies Inc
• Colorado State University
• Fujirebio Diagnostics Inc
• Genesis Detection Systems, Inc.
• Guanine Inc
• Hologic Inc
• Isoformix Inc
• Numares AG
• Ortho Clinical Diagnostics Holdings Plc
• Ottawa Hospital Research Institute
• Roche Diagnostics International Ltd
• Sebia SA
• Siemens Healthcare Diagnostics Inc
• SomaLogic Inc
• Umea University
• University of California

第6章 特定蛋白质- 最近的开发

第7章 附录

• 调查手法
• 关于GlobalData
• 询问
• 免责声明

GlobalData's Medical Devices sector report, "Specific Proteins Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" provides comprehensive information about the Specific Proteins pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Specific Proteins are reagents and test kits which are used to quantify and detect protein molecules from bodily fluids.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Specific Proteins under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Specific Proteins and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Specific Proteins under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Specific Proteins Overview

3 Products under Development

• 3.1 Specific Proteins - Pipeline Products by Stage of Development
• 3.2 Specific Proteins - Pipeline Products by Territory
• 3.3 Specific Proteins - Pipeline Products by Regulatory Path
• 3.4 Specific Proteins - Pipeline Products by Estimated Approval Date
• 3.5 Specific Proteins - Ongoing Clinical Trials

4 Specific Proteins - Pipeline Products under Development by Companies

• 4.1 Specific Proteins Companies - Pipeline Products by Stage of Development
• 4.2 Specific Proteins - Pipeline Products by Stage of Development

5 Specific Proteins Companies and Product Overview

• 5.1 Alfa Wassermann Diagnostic Technologies, LLC Company Overview
• 5.2 Amerimmune LLC Company Overview
• 5.3 Beckman Coulter Inc Company Overview
• 5.4 China Medical Technologies Inc (Inactive) Company Overview
• 5.5 Colorado State University Company Overview
• 5.6 Fujirebio Diagnostics Inc Company Overview
• 5.7 Genesis Detection Systems, Inc. Company Overview
• 5.8 Guanine Inc Company Overview
• 5.9 Hologic Inc Company Overview
• 5.10 Isoformix Inc Company Overview
• 5.11 Numares AG Company Overview
• 5.12 Ortho Clinical Diagnostics Holdings Plc Company Overview
• 5.13 Ottawa Hospital Research Institute Company Overview
• 5.14 Roche Diagnostics International Ltd Company Overview
• 5.15 Sebia SA Company Overview
• 5.16 Siemens Healthcare Diagnostics Inc Company Overview
• 5.17 SomaLogic Inc Company Overview
• 5.18 Umea University Company Overview
• 5.19 University of California Company Overview

6 Specific Proteins- Recent Developments

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer

List of Tables

List of Tables

• Specific Proteins - Pipeline Products by Stage of Development
• Specific Proteins - Pipeline Products by Territory
• Specific Proteins - Pipeline Products by Regulatory Path
• Specific Proteins - Pipeline Products by Estimated Approval Date
• Specific Proteins - Ongoing Clinical Trials
• Specific Proteins Companies - Pipeline Products by Stage of Development
• Specific Proteins - Pipeline Products by Stage of Development
• Glossary

List of Figures

List of Figures

• Specific Proteins - Pipeline Products by Stage of Development
• Specific Proteins - Pipeline Products by Territory
• Specific Proteins - Pipeline Products by Regulatory Path
• Specific Proteins - Pipeline Products by Estimated Approval Date
• Specific Proteins - Ongoing Clinical Trials